RT Journal Article
SR Electronic
T1 Dental adverse effects of sublingual buprenorphine and naloxone
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 115
OP 115
DO 10.1136/dtb.2023.000034
VO 61
IS 8
YR 2023
UL http://dtb.bmj.com/content/61/8/115.abstract
AB Overview of: Etminan M, Rezaeianzadeh R, Kezouh A, et al. Association between sublingual buprenorphine-naloxone exposure and dental disease. JAMA. 2022;328:2269-71.